More JAK therapies for atopic dermatitis expected in China
Danni Yin · 03/31/2022
China could soon see a stream of foreign and homegrown JAK inhibitors being cleared or tested for atopic dermatitis, as competition among local players is heating up.
China approved more drugs for atopic dermatitis in February
Danni Yin · 03/09/2022
Chinese regulators approved 11 drugs in February. Uses and indications ran a wide gamut, including two drugs for atopic dermatitis and six new molecular entities that were approved for the first time.
Sanofi’s Dupixent approved in China for atopic dermatitis in patients aged 12 and above
Elise Mak · 09/10/2021
This is one of the two applications that Sanofi submitted for new indication approvals.
Copyright © 2016-2022 PharmaDJ .All Rights Reserved.   Suggestions and feedback:   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement